GlassScriptPhysician profile
Joel Ciolek
NPI 1487111365
$3,569.93
in general payments reported to CMS, 2019-2025
11 companies · $680 in 2025
The $680 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $125 · 2024: $2,765 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,028 · Food and Beverage: $1,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,027.74 |
| Food and Beverage | $1,542.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $2,698.12 | 2024 | |
| Abbvie INC. | $262.26 | 2023-2025 | |
| Alcon Vision LLC | $208.72 | 2025 | Tryptyr |
| Astellas Pharma US INC | $135.67 | 2025 | Izervay |
| Dompe US, INC. | $63.23 | 2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $41.56 | 2025 | |
| Oyster Point Pharma, INC. | $38.56 | 2025 | Tyrvaya |
| Genentech USA, INC. | $38.22 | 2024 | Vabysmo |
| Mallinckrodt Hospital Products INC. | $29.09 | 2025 | Acthar |
| Ocular Therapeutix, INC. | $28.97 | 2024 | Dextenza |
| Tarsus Pharmaceuticals, INC. | $25.53 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Ciolek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.